| AASLD | American Association for the study of Liver Diseases |
| AFP | α-Fetoprotein |
| AFP-L3 | Lens culinaris-agglutinin-reactive fraction of AFP |
| AGA | American Gastroenterology Association |
| AIM | Apoptosis inhibitor of macrophage |
| AST | aspartate aminotransferase |
| ALT | alanine aminotransferase |
| BMI | body mass index |
| HA | hyaluronic acid |
| P3NP | aminoterminal propeptide of type 3 procollagen |
| TIMP-1 | tissue inhibitor of matrix metalloproteinase type 1 |
| CTC | circulating tumor cells |
| CfDNA | cell-free DNA |
| cfRNA | cell-free RNA |
| EV | extracellular vesicle |
| DCP | des-γ-carboxy pro-thrombin |
| CI | confidence interval |
| CT | computed tomography |
| ELF | enhanced liver fibrosis |
| ELISA | enzyme linked immunosolvent assay |
| FIB-4 | Fibrosis-4 |
| NFS | NAFLD fibrosis score |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| HCC | hepatocellular carcinoma |
| HR | hazard ratio |
| HSD17B13 | hydroxysteroid 17- beta dehydrogenase 13 |
| FLD | fatty liver disease |
| M2BPGi | Mac-2 binding protein glycosylation isomer |
| MBOAT7 | membrane bound O-acyl-transferase domain circulating 7 |
| MDCT | multidetector CT |
| miRNA | microRNA |
| MRE | magnetic resonance elastography |
| MRI | magnetic resonance imaging |
| ECCM-MRI | extracellular contrast media-enhanced MRI |
| NAFLD | nonalcoholic fatty liver disease |
| NASH | nonalcoholic steatohepatitis |
| NIT | noninvasive test |
| TIMP-1 | tissue inhibitor of matrix metalloproteinase type 1, |
| PIVKA-II | protein induced by vitamin K |
| P3NP | aminoterminal propeptide of type 3 procollagen |
| PNPLA3 | patatin-like phospholipase domain-containing protein 3 |
| QALY | quality-adjusted life year |
| RIA | radioimmunoassay |
| SNP | single nucleotide polymorphism |
| TIMP-1 | tissue inhibitor of matrix metalloproteinase type 1 |
| TM6SF | transmembrane 6 superfamily member 2 |
| US | ultrasonography |
| VCTE | vibration-controlled transient elastography |